Literature DB >> 10591334

Elevated C-reactive protein levels in overweight and obese adults.

M Visser1, L M Bouter, G M McQuillan, M H Wener, T B Harris.   

Abstract

CONTEXT: Human adipose tissue expresses and releases the proinflammatory cytokine interleukin 6, potentially inducing low-grade systemic inflammation in persons with excess body fat.
OBJECTIVE: To test whether overweight and obesity are associated with low-grade systemic inflammation as measured by serum C-reactive protein (CRP) level. DESIGN AND
SETTING: The Third National Health and Nutrition Examination Survey, representative of the US population from 1988 to 1994. PARTICIPANTS: A total of 16616 men and nonpregnant women aged 17 years or older. MAIN OUTCOME MEASURES: Elevated CRP level of 0.22 mg/dL or more and a more stringent clinically raised CRP level of more than 1.00 mg/dL.
RESULTS: Elevated CRP levels and clinically raised CRP levels were present in 27.6% and 6.7% of the population, respectively. Both overweight (body mass index [BMI], 25-29.9 kg/m2) and obese (BMI, > or =30 kg/m2) persons were more likely to have elevated CRP levels than their normal-weight counterparts (BMI, <25 kg/m2). After adjustment for potential confounders, including smoking and health status, the odds ratio (OR) for elevated CRP was 2.13 (95% confidence interval [CI], 1.56-2.91) for obese men and 6.21 (95% CI, 4.94-7.81) for obese women. In addition, BMI was associated with clinically raised CRP levels in women, with an OR of 4.76 (95% CI, 3.42-6.61) for obese women. Waist-to-hip ratio was positively associated with both elevated and clinically raised CRP levels, independent of BMI. Restricting the analyses to young adults (aged 17-39 years) and excluding smokers, persons with inflammatory disease, cardiovascular disease, or diabetes mellitus and estrogen users did not change the main findings.
CONCLUSION: Higher BMI is associated with higher CRP concentrations, even among young adults aged 17 to 39 years. These findings suggest a state of low-grade systemic inflammation in overweight and obese persons.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10591334     DOI: 10.1001/jama.282.22.2131

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  604 in total

Review 1.  Vascular inflammation as a therapeutic target for prevention of cardiovascular disease.

Authors:  Luther T Clark
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

Review 2.  Complex interactions in complex traits: obesity and asthma.

Authors:  K G Tantisira; S T Weiss
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

3.  Body Mass Index Mediates the Association between Dietary Fiber and Symptomatic Knee Osteoarthritis in the Osteoarthritis Initiative and the Framingham Osteoarthritis Study.

Authors:  Zhaoli Dai; S Reza Jafarzadeh; Jingbo Niu; David T Felson; Paul F Jacques; Shanshan Li; Yuqing Zhang
Journal:  J Nutr       Date:  2018-12-01       Impact factor: 4.798

4.  Drug-disease interactions: reduced beta-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat.

Authors:  K M Kulmatycki; K Abouchehade; S Sattari; F Jamali
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

5.  IgG receptor FcγRIIB plays a key role in obesity-induced hypertension.

Authors:  Nathan C Sundgren; Wanpen Vongpatanasin; Brigid-Meghan D Boggan; Keiji Tanigaki; Ivan S Yuhanna; Ken L Chambliss; Chieko Mineo; Philip W Shaul
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

6.  Serum leptin level mediates the association of body composition and serum C-reactive protein in HIV-infected persons on antiretroviral therapy.

Authors:  John R Koethe; Aihua Bian; Ayumi K Shintani; M Sean Boger; Valerie J Mitchell; Husamettin Erdem; Todd Hulgan
Journal:  AIDS Res Hum Retroviruses       Date:  2012-02-02       Impact factor: 2.205

7.  Neighborhoods and systemic inflammation: high CRP among legal and unauthorized Brazilian migrants.

Authors:  Louisa M Holmes; Enrico A Marcelli
Journal:  Health Place       Date:  2012-01-16       Impact factor: 4.078

8.  A QTL on 12q influencing an inflammation marker and obesity in white women: the NHLBI Family Heart Study.

Authors:  Jun Wu; James S Pankow; Russell P Tracy; Kari E North; Richard H Myers; Mary E Feitosa; Michael A Province; Ingrid B Borecki
Journal:  Obesity (Silver Spring)       Date:  2008-12-25       Impact factor: 5.002

Review 9.  Role of inflammatory pathways in the development and cardiovascular complications of type 2 diabetes.

Authors:  Milagros G Huerta; Jerry L Nadler
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

10.  Body fat, body fat distribution, lean body mass and atrial fibrillation and flutter. A Danish cohort study.

Authors:  Lars Frost; Emelia J Benjamin; Morten Fenger-Grøn; Asger Pedersen; Anne Tjønneland; Kim Overvad
Journal:  Obesity (Silver Spring)       Date:  2014-02-18       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.